FARNUM RHONDA (SVP, Comm & Medical Affairs) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/24/2025ACC: 0001898490-25-000006
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-9.06K
Net shares
Net seller
$162.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.06K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−9.06K
Price / share
$17.90
Trade value
$162.17K
% of position
2.9%
11/20/2025
317.82K→308.76K
Total
Net shares
−9.06K
Net value
-$162.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2025 | F · Tax Withholding | −9.06K | $17.90 | $162.17K | 2.9% | 317.82K | 308.76K |
| Total | −9.06K | -$162.17K | ||||||
Derivative Transactions0
No derivative transactions reported